Daily BriefsTMT/Internet

Daily Brief TMT/Internet: Wonik Ips, Nintendo, Dassault Systemes and more

In today’s briefing:

  • Watch This Friday’s TIGER Top 10 Semicon Rebalance
  • Nintendo (7974) | Next-Gen Switch 2 Meets Next-Level Margin Risk
  • Dassault Systèmes (DSY FP): Siemens Finally Moves onto Biovia’s Territory


Watch This Friday’s TIGER Top 10 Semicon Rebalance

By Sanghyun Park

  • After the March avg daily market cap screen, Wonik IPS is swapped for Jusung Engineering. Big passive impact expected—Jusung gets 1x ADTV buy flow, Wonik faces 2.6x ADTV sell.
  • Watch for passive flow timing—last rebalance (Oct 11), ISC Co Ltd got kicked, Wonik IPS called up. TIGER split Wonik’s rebalance over two trading days to minimize price impact.
  • The long/short yield was 2.89% on Oct 11, 3.96% over two days. With bigger passive flow impact, TIGER may split the rebalance—enter near Thursday close, exit by Monday afternoon.

Nintendo (7974) | Next-Gen Switch 2 Meets Next-Level Margin Risk

By Mark Chadwick

  • Tariff Headwinds: U.S. import tariffs could wipe out hardware margins, potentially costing Nintendo up to ¥95bn in FY3/26 gross profit.
  • Guidance Risk: With bullish consensus expecting ¥450bn in FY3/26 operating profit, upcoming guidance on July 5 may significantly disappoint.
  • Valuation Hinges on Recovery: FY3/27 earnings could rebound to ¥600bn if cycle normalises and tariff risks ease—implying a fair 13x EV/EBIT multiple.

Dassault Systèmes (DSY FP): Siemens Finally Moves onto Biovia’s Territory

By Gregory Ramirez

  • Siemens is acquiring Dotmatics, a SaaS provider for laboratory management, for USD 5.1bn. The acquisition, which is seen as expensive, reflects high multiples of 16.5x EV/sales for FY 2025.  
  • This acquisition strengthens Siemens’ position in life sciences by expanding its industrial software offerings. Dotmatics adds a new USD 5.5bn market opportunity, which could grow to USD 11bn.   
  • Siemens’ entry into life sciences may challenge Dassault Systèmes, which currently leads the market with its Biovia and Medidata platforms. Siemens’ growing presence in this sector may intensify competition.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars